1.
Elsamany SA, Elemam O, Hassanin F, Algahami A, Alghanmi H, El naghi KAEA. Neoadjuvant Chemotherapy Plus Denosumab Compared to Chemotherapy Alone in Hormonal Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Premenopausal Breast Cancer Patients. World J Oncol. 2025;16(5):502-508. doi:10.14740/wjon2546